Skip to main content
Top

Clinical & Experimental Metastasis

Issue 6/1999

Content (11 Articles)

Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential

François Capon, Hervé Emonard, William Hornebeck, François-Xavier Maquart, Philippe Bernard

Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas

Luis Antonio Parada, Antonio Marañon, Magnus Hallén, Karl-Göran Tranberg, Unne Stenram, Georgia Bardi, Bertil Johansson

Minimal liver resection strongly stimulates the growth of human colon cancer in the liver of nude mice

Babak Rashidi, Zili An, Fang-Xian Sun, Aaron Sasson, Reza Gamagammi, A.R. Moossa, Robert M. Hoffman

Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase

Katsuya Nakanishi, Jiro Fujimoto, Takahiro Ueki, Keigo Kishimoto, Tomoko Hashimoto-Tamaoki, Jun-ichi Furuyama, Toshifumi Itoh, Yutaka Sasaki, Eizo Okamoto

A three-dimensional in-vitro model for the study of peritoneal tumour metastasis

David G. Jayne, Ronan O'Leary, Andrew Gill, Adrian Hick, Pierre J. Guillou

Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility

Kohei Murata, Masao Kameyama, Fumiyo Fukui, Hiroaki Ohigashi, Masahiro Hiratsuka, Yo Sasaki, Toshiyuki Kabuto, Mutsuko Mukai, Tadanori Mammoto, Hitoshi Akedo, Osamu Ishikawa, Shingi Imaoka

Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry

Christina M. Schmidt, Steven L. Settle, Jeffery L. Keene, William F. Westlin, G. Allen Nickols, David W. Griggs

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine